About Gilead Sciences India Private Limited
Data last updated:
Gilead Sciences India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Gilead Alberta Llc. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 26 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74120DL2014FTC308398. Its GSTIN is 07AAFCG7248G1ZH (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Gsi Pharma Private Limited and Gilead India Private Limited. It is led by directors including Hans Yorkjulian Stucker and Janet Elizabeth Dorling.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1208 – 1209 12th Floor Vikrant Tower, Rajendra Place New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹11 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.07 Cr (net margin 9.7%) and EBITDA of ₹1.44 Cr (EBITDA margin 13.1%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 8% over five years.
The company is associated with 1 brand: Gilead.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gilead.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1208 – 1209 12th Floor Vikrant Tower, Rajendra Place New Delhi, Delhi, India – 110008
- IndustryTravel and Hospitality, Consumer Professional Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gilead Sciences India Private Limited
The main business activity of Gilead Sciences India is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gilead Sciences India Private Limited FY 2025 filings available
Gilead Sciences India Private Limited reported revenue of ₹11 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gilead Sciences India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 2% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gilead Sciences India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.44 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gilead Sciences India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gilead Sciences India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gilead Sciences India Private Limited
Gilead Sciences India Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Pharma Retail and Distribution, Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royale Meridian (India) Private Limited | ₹11.02 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | New Delhi, Delhi, India |
| Vandana Distributors Private Limited | ₹11.01 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Networth RCM Services Private Limited | ₹11.01 Cr (FY 2024) | •••• | •••• | 47.0% | •••• | Mohali, Punjab, India |
| Safeway Lifesciences Private Limited | ₹11.01 Cr (FY 2024) | •••• | •••• | 451.0% | •••• | Ahmedabad, Gujarat, India |
| Ecorys India Private Limited | ₹11.01 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| Gilead Sciences India Private Limited this company | ₹11 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Mattu Garments Private Limited | ₹11 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Mumbai, Maharashtra, India |
| Legalforce Rapc Private Limited | ₹11 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Bangalore, Karnataka, India |
| Assure Life Science Private Limited | ₹10.99 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | New Delhi, Delhi, India |
| Omtronix Services Private Limited | ₹10.98 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Bhubaneswar, Odisha, India |
| Unidesign & Concepts Private Limited | ₹10.98 Cr (FY 2024) | •••• | •••• | 68.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Gilead Sciences India by revenue in the Consumer Services industry (Pharma Retail and Distribution, Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gilead Sciences India Private Limited
Gilead Sciences India Private Limited is audited by S R B C & CO LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gilead Sciences India Private Limited
Gilead Sciences India has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hans Yorkjulian Stucker Also directs: Gilead Sciences India Private Limited | Director | 08 Aug 2023 | 3 Years 2 Months | Current |
| Janet Elizabeth Dorling Also directs: Gilead Sciences India Private Limited | Director | 08 Aug 2023 | 3 Years 2 Months | Current |
| Rahul Shivram Bargaje Also directs: Gilead Sciences India Private Limited | Director | 10 Jan 2018 | 8 Years 9 Months | Current |
| Sebastiano Cicognani Also directs: Gilead Sciences India Private Limited | Additional Director | 01 Oct 2025 | 1 Years 0 Months | Current |
Ownership and Shareholding of Gilead Sciences India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gilead Sciences India Private Limited
Gilead Sciences India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Gilead Sciences India Private Limited
Gilead Sciences India operates one associated brand: Gilead. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | gilead.com |
Employees and EPFO Compliance at Gilead Sciences India Private Limited
Employment history and EPFO contributions of people linked to Gilead Sciences India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Gilead Sciences India Private Limited
Gilead Sciences India has undergone 2 name changes throughout its history. The company was previously known as Gsi Pharma Private Limited, and Gilead India Private Limited. The current legal name is Gilead Sciences India Private Limited.
| Company Name | Status |
|---|---|
| Gilead Sciences India Private Limited | Current |
| Gsi Pharma Private Limited | Previous |
| Gilead India Private Limited | Previous |
CIN History of Gilead Sciences India Private Limited
Gilead Sciences India has one previous CIN (Corporate Identification Number): U74120MH2014FTC256644. The current CIN is U74120DL2014FTC308398, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74120DL2014FTC308398 | Current |
| U74120MH2014FTC256644 | Previous |
News related to Gilead Sciences India Private Limited
Recent Activity on Gilead Sciences India Private Limited
Gilead Sciences India Private Limited has 16 board changes on record since 2015: 4 appointments and 12 cessations. The latest: Sebastiano Cicognani was appointed as Additional Director on 01 Oct 2025.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Gilead Sciences India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gilead Sciences India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gilead Sciences India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gilead Sciences India Private Limited
Gilead Sciences India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCG7248G1ZH | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gilead Sciences India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gilead Sciences India Private Limited
Gilead Sciences India is an active foreign private limited company based in New Delhi, Delhi, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 26 July 2014 (12+ years old) and is registered under CIN U74120DL2014FTC308398.
Gilead Sciences India reported revenue of ₹11 Cr for FY 2024 (up 2% YoY).
Gilead Sciences India has 4 current directors:
- Hans Yorkjulian Stucker - Director
- Janet Elizabeth Dorling - Director
- Rahul Shivram Bargaje - Director
- Sebastiano Cicognani - Additional Director
Gilead Sciences India reported a net profit of ₹1.07 Cr (net margin 9.7%) and EBITDA of ₹1.44 Cr (EBITDA margin 13.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gilead Sciences India is 33% over three years and 8% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gilead Sciences India is 07AAFCG7248G1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Gilead Sciences India is U74120DL2014FTC308398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gilead Sciences India was incorporated on 26 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Gilead Sciences India by revenue are Royale Meridian (India) Private Limited, Vandana Distributors Private Limited, Networth RCM Services Private Limited, Safeway Lifesciences Private Limited, Ecorys India Private Limited and 5 more, all in the Consumer Services industry (Pharma Retail and Distribution, Professional Services).
Sebastiano Cicognani was appointed as Additional Director on 01 Oct 2025. Hans York-Julian Stucker ceased to be Additional Director on 28 Sep 2023. Janet Elizabeth Dorling ceased to be Additional Director on 28 Sep 2023. Gilead Sciences India has 16 board changes on record in total.
Gilead Sciences India can be reached through the website gilead.com. Its registered office is in New Delhi, Delhi, India.